Very long term studies of the seeding of beta-amyloidosis in primates.

J Neural Transm (Vienna)

MRC Comparative Cognition Team, Department of Experimental Psychology, Cambridge, United Kingdom.

Published: September 2006

Cerebral beta-amyloidosis was found in 16/18 marmosets aged <10 yrs and 8/9 marmosets aged >10 yrs, injected intracerebrally with human or marmoset brain homogenate containing beta-amyloid 1-8 years previously. It was found in only 2/12 marmosets aged <10 yrs and 1/15 marmosets aged >10 yrs, injected with synthetic Abeta-peptides, CSF, or brain tissue which did not contain beta-amyloid. Cerebral beta-amyloidosis was found in 0/11 uninjected marmosets aged <10 yrs and in 5/29 uninjected marmosets aged >10 yrs. The beta-amyloidosis comprised small and large vessel angiopathy and some plaques throughout cortex and was qualitatively similar in injected marmosets and, when present, in uninjected marmosets. Of those injected marmosets which were positive, the amount of beta-amyloidosis was unrelated to age or incubation times but the 3 injected marmosets without beta-amyloidosis had incubation times of <3.5 years. We conclude that beta-amyloid, or associated factors, can initiate or accelerate the process of cerebral amyloidosis in primates.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-005-0385-2DOI Listing

Publication Analysis

Top Keywords

marmosets aged
12
aged yrs
12
injected marmosets
12
cerebral beta-amyloidosis
8
yrs injected
8
uninjected marmosets
8
incubation times
8
marmosets
7
beta-amyloidosis
6
injected
5

Similar Publications

Lung ultrasound can be useful for the early diagnosis and treatment of respiratory complications. The combination of air and soft tissue confirms imaging artefacts that can contribute to differentiation between healthy and deteriorated lung tissue. Although non-human primates are often chosen as research models due to their anatomical and physiological similarity to humans, there is a lack of data on the use of lung ultrasound in these individuals.

View Article and Find Full Text PDF

Menopausal symptoms of sleep disturbances, cognitive deficits, and hot flashes are understudied, in part due to the lack of animal models in which they co-occur. Common marmosets (Callithrix jacchus) are valuable nonhuman primates for studying these symptoms, and we examined changes in cognition (reversal learning), sleep (48 h/wk of sleep recorded by telemetry), and thermoregulation (nose temperature in response to mild external warming) in middle-aged, surgically-induced menopausal marmosets studied at baseline, during 3-week phases of ethinyl estradiol (EE, 4 μg/kg/day, p.o.

View Article and Find Full Text PDF

Introduction: The fragile brain includes both the developing brain in childhood and the deteriorating brain in elderly. While the effects of general anesthesia on the myelin sheath of developing brain have been well-documented, limited research has explored its impact on degenerating brain in elderly individuals.

Methods: In our study, aged marmosets in control group were only anesthetized with 6-8% sevoflurane and 100% oxygen (2 L/min) for 1-2 min for anesthesia induction.

View Article and Find Full Text PDF

Post-mortem diagnosis of human rabies in SARS-CoV-2 coinfected patient with minimally invasive autopsy in northeastern Brazil.

J Infect Dev Ctries

July 2024

Department of Infectious Diseases of Hospital das Clínicas and Laboratório de Investigação Médica - LIM 49, University of São Paulo, São Paulo, Brazil.

Article Synopsis
  • Human rabies is a deadly disease caused by lyssaviruses, and there has been an increase in cases following the COVID-19 pandemic.
  • A case from Ceará, Brazil in 2023 involved a patient bitten by a marmoset who was also co-infected with SARS-CoV-2, diagnosed using minimally invasive autopsy (MIA).
  • MIA is beneficial for its biosafety and efficiency, reducing body disfigurement and enhancing rabies diagnostics and family cooperation in tracking the disease.
View Article and Find Full Text PDF

Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases.

Neuron

August 2024

Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; Department of Neuroetiology and Diagnostic Science, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.

Article Synopsis
  • A new small-molecule ligand called C05-05 has been developed to visualize α-synuclein deposits in the brains of living subjects, which is important for understanding Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
  • In studies involving mouse and marmoset models, C05-05 enabled detection of dynamic changes in α-synuclein fibril formation and structural disruptions within neural pathways.
  • PET imaging revealed that C05-05 signals were significantly stronger in the midbrains of PD and DLB patients compared to healthy individuals, suggesting its potential for diagnostic and therapeutic advancements in these conditions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!